Try our Advanced Search for more refined results

Deals Rumor Mill: Novartis, I-Med Radiology, Kaltura

By Benjamin Horney (November 1, 2017, 7:05 PM EDT) -- Switzerland-based Novartis AG may sell its dermatology generic-drug division, according to a Wednesday report from Bloomberg. According to the report, the potential divestiture would be part of an overall effort from Novartis to get rid of parts of its business that haven't been very profitable while refocusing on other areas, including cancer treatments. The business that is up for grabs could be worth as much as $1.5 billion, and suitors could include private equity firms or other drug companies, the report said....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!